GlassScriptPhysician profile
Krishna R Nayini
NPI 1326158890
$2,375.87
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $185 · 2021: $685 · 2022: $596 · 2023: $198 · 2024: $80.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $513.20 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $382.43 | 2019-2022 | |
| Medtronic Vascular, INC. | $342.88 | 2019-2020 | |
| Edwards Lifesciences Corporation | $274.29 | 2019-2021 | |
| Irhythm Technologies, INC. | $145.22 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Gilead Sciences, INC. | $87.40 | 2019 | |
| Philips North America LLC | $82.94 | 2023 | |
| Merck Sharp & Dohme LLC | $82.17 | 2022-2023 | Verquvo |
| Pfizer INC. | $79.42 | 2020-2022 | |
| Medtronic, INC. | $71.98 | 2021 | |
| Amgen INC. | $55.32 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $53.66 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $49.08 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $35.21 | 2022 | |
| Amarin Pharma, INC. | $32.17 | 2019-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $29.52 | 2022 | |
| Abbott Laboratories | $26.61 | 2019 | |
| Biotronik INC. | $18.24 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Nayini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.